Physician profile
Crystal James
NPI 1255788584
$4,795.54
in general payments reported to CMS, 2019-2025
10 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.81 · 2020: $38.36 · 2022: $18.32 · 2023: $3,131 · 2024: $1,422 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,098 · Food and Beverage: $1,718 · Education: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,098.33 |
| Food and Beverage | $1,718.30 |
| Education | $839.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,921.69 | 2023-2024 | Endurant Iis |
| W. L. Gore & Associates, INC. | $976.58 | 2023-2024 | Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Cook Medical LLC | $656.60 | 2024-2025 | Cook, Zenith Alpha, Zilver Ptx |
| Becton, Dickinson and Company | $82.81 | 2019 | |
| Bolton Medical INC | $42.57 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Davol INC. | $31.37 | 2024 | Arista Ah Flexitip |
| Medtronic Vascular, INC. | $27.39 | 2020 | |
| Acera Surgical, INC. | $27.24 | 2025 | Restrata Wound Matrix |
| Lemaitre Vascular, INC. | $18.32 | 2022 | |
| Janssen Pharmaceuticals, INC | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.